The Food and Drug Administration (FDA) has recommended that hydrocodone-containing combination products, such as hydrocodone/acetaminophen (Vicodin) not be put under tighter regulation. This means it should retain its .
Recently, the Drug Enforcement Agency (DEA) has made moves to change Vicodin’s scheduling, claiming it qualifies as a Schedule II drug due to similar abuse potentials shared with that category.
While it is clear drugs like Vicodin are being abused, no objective standard exists with which to compare the level of scheduling. Hydrocodone by itself already qualifies as a Schedule II.
Such a scheduling change would limits prescriptions and refills. The changes for fibromyalgia patients would be massive.
Powered by Facebook Comments